Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 32
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
2/1/1988
1.
Phase I/II Chemotherapy with AT-125/CACP in Patients with non-Small Cell Carcinoma of the Lung (Summary Last Modified 02/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
18 to 80
NCI
CAN-NCIC-IND17
NCI-T84-0489W, T84-0489, IND17
2.
Phase II Chemotherapy with Acivicin for Advanced Colorectal and Pancreatic Cancers
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15 and over
MDA-DT-8135
3.
Phase II Chemotherapy with Acivicin for Recurrent, Metastatic, or Nonresectable Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
CLB-8341
4.
Phase II Pilot Evaluation of Acivicin for Dukes D or Recurrent, Inoperable Colorectal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
16 and over
NCI
EST-PD-281
EST-P-D281
Last Modified:
4/26/2007
5.
Phase II Master Protocol for Chemotherapy for Recurrent or Stage IV Renal Cell Carcinoma --- VBL vs L-Alanosine vs Acivicin vs CTX vs Misonidazole vs Aminothiadiazole
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-1882
6.
Phase II Master Protocol for Evaluation of New Agents for Previously Treated Metastatic Breast Cancer --- AT-125, A-TDA
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-2182
Last Modified:
9/19/2006
7.
Phase II Master Protocol for Evaluation of New Agents for Residual, Recurrent, or Metastatic Primary Liver Cancer --- Acivicin vs 4'-Deoxydoxorubicin
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-2282
8.
Phase II Master Protocol Chemotherapy for Previously Treated Stage III/IV Ovarian Adenocarcinoma --- VBL vs AT-125
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-5882
9.
Phase II Master Protocol Chemotherapy for Inoperable, Metastatic Malignant Melanoma --- VBL; AT-125; CBDCA; FAMP; CCNU; Alpha-2-Interferon
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-2683
10.
Phase II Master Protocol for Advanced, Recurrent Pelvic Malignancies: AT-125
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
GOG-26P
GOG-26P
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute